Latest Breaking News On - Inserm transfert - Page 4 : comparemela.com

Tonix Pharma (TNXP) Presents Non-Clinical Data on TNX-2900

Tonix Pharmaceuticals Holding Corp executive presents data on Prader-Willi Syndrome drug at Rare Disease Innovation and Partnership Summit in Philadelphia

Tonix Pharmaceuticals (NASDAQ:TNXP) Holding Corp EVP of translation medicine Herbert Harris delivered an oral presentation Thursday at the Rare Disease.

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2022 AND ANNOUNCES ORGANIZATIONAL CHANGES

Lyon, France - 18 January 2023 - 7.30am CET - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating

THERANEXUS AND INSERM TRANSFERT SIGN A STRATEGIC ALLIANCE TO IDENTIFY ADVANCED THERAPY DRUG CANDIDATES FOR RARE NEUROLOGICAL DISEASES

Lyon, Paris, France - 20th October 2022 - 6 pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates

Global Companion Diagnostics Partnering Deals Report 2022: Access to over 500 Deals Signed Since 2010

/PRNewswire/ The "Global Companion Diagnostics Partnering Terms and Agreements 2010-2022" report has been added to ResearchAndMarkets.com s offering. The.